WHO ICTRP trial
Investigation of the efficacy and safety of ledipasvir and sofosbuvir therapy…
JPRN-UMIN000031239 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000031239 |
|---|---|
| Public title | Investigation of the efficacy and safety of ledipasvir and sofosbuvir therapy for Genotype 1 Hepatitis C Virus infection in patients with decompensated cirrhosis |
| Scientific title | Investigation of the efficacy and safety of ledipasvir and sofosbuvir therapy for Genotype 1 Hepatitis C Virus infection in patients with decompensated cirrhosis - LDF/SOF for decompensated cirrhosis |
| Primary sponsor | Osaka University Graduate School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Decompensated cirrhosis by Genotype 1 Hepatitis C Virus infection |
| Interventions | Ledipasvir(90mg)/sofosbuvir(400mg) for 12 weeks |
| Registration date | Jan 5, 2018 |
| Target size | 15 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: